Advanced Medical Solutions Group plc (AIM:AMS)

Market Cap	487.39M
Revenue (ttm)	220.30M
Net Income (ttm)	9.12M
Shares Out	215.66M
EPS (ttm)	0.04
PE Ratio	54.18
Forward PE	18.23
Dividend	0.03 (1.19%)
Ex-Dividend Date	Sep 25, 2025

Volume	2,628,405
Average Volume	651,904
Open	207.00
Previous Close	207.50
Day's Range	206.50 - 248.50
52-Week Range	168.40 - 243.86
Beta	0.63
RSI	63.02
Earnings Date	Dec 16, 2025

About AIM:AMS

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and Acti...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Employees: 1,600
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AMS

Financial Performance

In 2024, AIM:AMS's revenue was 177.52 million, an increase of 40.66% compared to the previous year's 126.21 million. Earnings were 7.09 million, a decrease of -55.35%.